ADR120S Inc (3750)

Currency in JPY
914.0
+1.0(+0.11%)
Closed·
3750 Scorecard
Full Analysis
Suffers from weak gross profit margins
3750 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
909.0914.0
52 wk Range
642.0990.0
Key Statistics
Bid/Ask
912.00 / 914.00
Prev. Close
913
Open
913
Day's Range
909-914
52 wk Range
642-990
Volume
4.6K
Average Volume (3m)
11.31K
1-Year Change
0.11%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
3750 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a poor free cash flow yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Neutral
Moving Averages
Strong Buy

ADR120S Inc Company Profile

ADR120S, Inc. engages in the research, development, production, and sale of cell therapy related medical devices in Japan. The company sells cell therapy kits, as well as engages in the research and development of cell therapy technology, etc. Its products pipeline includes ECCI-50 for the treatment of male stress urinary incontinence and liver cirrhosis; and Cyt-006 to prevent postoperative adhesion for primary rectal cancer. The company is also conducting clinical trials/research on cell therapy for a range of diseases and applications, including anterior cruciate ligament repair, bone repair, burn scars, chronic wound healing, critical limb ischemia, anal and Crohn’s disease fistulas, erectile dysfunction, etc. It also invests in, owns, develops, leases, and manages real estate projects and hotels; and provides real estate brokerage services. The company was formerly known as Cytori Cell Research Institute, Inc. and changed its name to ADR120S, Inc. in July 2025. ADR120S, Inc. was incorporated in 2004 and is headquartered in Tokyo, Japan.

Employees
10
Market
Japan

Compare 3750 to Peers and Sector

Metrics to compare
3750
Peers
Sector
Relationship
P/E Ratio
−3.8x7.7x9.0x
PEG Ratio
0.00−0.080.01
Price/Book
12.9x1.3x0.9x
Price / LTM Sales
66.8x0.9x3.9x
Upside (Analyst Target)
-−9.6%12.7%
Fair Value Upside
Unlock−15.3%0.4%Unlock

Earnings

Latest Release
Jun 27, 2025
EPS / Forecast
-155.57 / --
Revenue / Forecast
7.00M / --
EPS Revisions
Last 90 days

3750 Income Statement

FAQ

What Stock Exchange Does ADR120S Trade On?

ADR120S is listed and trades on the Tokyo Stock Exchange stock exchange.

What Is the Stock Symbol for ADR120S?

The stock symbol for ADR120S is "3750."

What Is the ADR120S Market Cap?

As of today, ADR120S market cap is 8.15B.

What Is ADR120S's Earnings Per Share (TTM)?

The ADR120S EPS (TTM) is -239.69.

When Is the Next ADR120S Earnings Date?

ADR120S will release its next earnings report on 06 Nov 2025.

From a Technical Analysis Perspective, Is 3750 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has ADR120S Stock Split?

ADR120S has split 3 times.

How Many Employees Does ADR120S Have?

ADR120S has 10 employees.

What is the current trading status of ADR120S (3750)?

As of 15 Aug 2025, ADR120S (3750) is trading at a price of 914.00, with a previous close of 913.00. The stock has fluctuated within a day range of 909.00 to 914.00, while its 52-week range spans from 642.00 to 990.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.